AccScience Publishing / JCTR / Volume 8 / Issue 3 / DOI: 10.18053/jctres.08.202203.003
REVIEW ARTICLE

Animal models in lymph node transfer surgery: A systematic review

Abdullah S. Eldaly1 Francisco R. Avila1 Ricardo A. Torres-Guzman1 Karla C. Maita1 John P. Garcia1 Luiza P. Serrano1 Humza Y. Saleem2 Antonio J. Forte1 *
Show Less
1 Division of Plastic Surgery, Mayo Clinic, Jacksonville, Florida, United States
2 Department of General Surgery, Mayo Clinic, Jacksonville, Florida, United States
Submitted: 22 December 2021 | Revised: 15 March 2022 | Accepted: 22 March 2022 | Published: 25 May 2022
© 2022 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution -Noncommercial 4.0 International License (CC-by the license) ( https://creativecommons.org/licenses/by-nc/4.0/ )
Abstract

Background and aim: Lymph node transfer surgery (LNTS) is indicated in secondary lymphedema patients who do not respond to conservative therapy. Animal models are the spearhead of lymphedema research and were used to pioneer most of the surgical interventions currently in practice. We conducted a systematic review of the literature to explore animal models dedicated to lymph node transfer surgery to compare different species, techniques, and outcomes.

Methods: Four databases were searched: PubMed, Cumulative Index of Nursing and Allied Health Literature (CINAHL), Scopus, and Web of Science. We used the Preferred Reporting Items for Systematic Reviews and Meta-Analysis as our basis of organization.

Results: Avascular lymph node graft (ALNG) and vascularized lymph node transfer (VLNT) effectively treated lymphedema and lead to better outcomes than controls. Whole ALNGs are superior to fragmented ALNGs. Larger fragments are more likely to be reintegrated into the lymphatic system than small fragments. VLNT was superior to whole and fragmented ALNG. Increasing the number of VLNT resulted in better outcomes. Adipose-derived stem cells improved outcomes of VLNT; vascular endothelial growth factor C and D, and platelet rich plasma improved outcomes for ALNG. Cryopreservation of lymph nodes did not affect outcomes for ALNG. The critical ischemia and venous occlusion time for LN flaps were 4-5 and 4 hours, respectively. The critical time for reperfusion injury was 2 hours. Some of the novel models included venous LNT, and cervical adipo-cutaneous flap to groin.

Conclusion: Current evidence from animals favors VLNT over other surgical interventions. Several pharmacological therapies significantly improved outcomes of ALNG and VLNT.

Relevance to patients: Lymphedema is a chronic condition affecting millions of patients worldwide. Lymph node transfer surgery is becoming more popular as a lymphedema treatment. Animal models have led the lymphedema research for decades and developing new models for lymphedema is essential for lymphedema research. This systematic review aims to summarize the existing animal models dedicated to lymph node transfer surgery. We believe this review is critical to guide researchers in the selection of the model that is best fit for their hypothesis-driven experiments.

Keywords
lymphedema
animal models
lymphedema surgery
systematic review
Conflict of interest
None of the authors have any conflicts of interest.
References

[1] Warren AG, Brorson H, Borud LJ, Slavin SA. Lymphedema: A Comprehensive Review. Ann Plastic Surg 2007;59:464-72.

[2] Kitsiou-Tzeli S, Vrettou C, Leze E, Makrythanasis P, Kanavakis E, Willems P. Milroy’s Primary Congenital Lymphedema in a Male Infant and Review of the Literature. In vivo (Athens, Greece) 2010;24:309-14.

[3] Bolletta A, Di Taranto G, Chen SH, Elia R, Amorosi V, Chan JC, et al. Surgical Treatment of Milroy Disease. J Surg Oncol 2020;121:175-81.

[4] Wheeler ES, Chan V, Wassman R, Rimoin DL, Lesavoy MA. Familial Lymphedema Praecox: Meige’s Disease. Plastic Reconstruct Surg 1981;67:362-4.

[5] Szuba A, Shin WS, Strauss HW, Rockson S. The Third Circulation: Radionuclide Lymphoscintigraphy in the Evaluation of Lymphedema. J Nuclear Med 2003;44:43-57.

[6] Becker C, Vasile JV, Levine JL, Batista BN, Studinger RM, Chen CM, et al. Microlymphatic Surgery for the Treatment of Iatrogenic Lymphedema. Clin Plastic Surg 2012;39:385-98.

[7] International Society of Lymphology. The Diagnosis and Treatment of Peripheral Lymphedema. Consensus Document of the International Society of Lymphology. Lymphology 2003;36:84-91.

[8] Ruocco V, Schwartz RA, Ruocco E. Lymphedema: An Immunologically Vulnerable Site for Development of Neoplasms. J Am Acad Dermatol 2002;47:124-7.

[9] Grada AA, Phillips TJ. Lymphedema: Pathophysiology and Clinical Manifestations. J Am Acad Dermatol 2017;77:1009-20.

[10] Sharma A, Schwartz RA. Stewart-Treves Syndrome: Pathogenesis and Management. J Am Acad Dermatol 2012;67:1342-8.

[11] Oremus M, Dayes I, Walker K, Raina P. Systematic Review: Conservative Treatments for Secondary Lymphedema. BMC Cancer 2012;12:6.

[12] Hadamitzky C, Pabst R, Gordon K, Vogt PM. Surgical Procedures in Lymphedema Management. J Vasc Surg Venous Lymphat Disord 2014;2:461-8.

[13] Cormier JN, Rourke L, Crosby M, Chang D, Armer J. The Surgical Treatment of Lymphedema: A Systematic Review of the Contemporary Literature (2004-2010). Ann Surg Oncol 2012;19:642-51.

[14] Casley-Smith JR, Morgan RG, Piller NB. Treatment of Lymphedema of the Arms and Legs with 5,6-benzo-alpha.- pyrone. N Engl J Med 1993;329:1158-63.

[15] Loprinzi CL, Sloan J, Kugler J. Coumarin-induced Hepatotoxicity. J Clin Oncol 1997;15:3167-8.

[16] Paskett ED, Stark N. Lymphedema: Knowledge, Treatment, and Impact Among Breast Cancer Survivors. Breast J 2000;6:373-8.

[17] Rockson SG, Miller LT, Senie R, Brennan MJ, CasleySmith JR, Földi E, et al. American Cancer Society Lymphedema Workshop. Workgroup III: Diagnosis and Management of Lymphedema. Cancer 1998;83:2882-5.

[18] Gloviczki P. Principles of Surgical Treatment of Chronic Lymphoedema. Int Angiol 1999;18:42-6.

[19] Weiss M, Baumeister RG, Hahn K. Post-therapeutic Lymphedema: Scintigraphy Before and after Autologous Lymph Vessel Transplantation: 8 Years of Long-term follow-up. Clin Nucl Med 2002;27:788-92.

[20] Lin CH, Ali R, Chen SC, Wallace C, Chang YC, Chen HC, et al. Vascularized Groin Lymph Node Transfer using the Wrist as a Recipient Site for Management of Postmastectomy Upper Extremity Lymphedema. Plastic Reconstruct Surg 2009;123:1265-75.

[21] Brorson H, Svensson H. Liposuction Combined with Controlled Compression Therapy Reduces Arm Lymphedema more Effectively than Controlled Compression Therapy Alone. Plast Reconstruct Surg 1998;102:1058-67.

[22] Hadamitzky C, Pabst R. Acquired Lymphedema: An Urgent Need for Adequate Animal Models. Cancer Res 2008;68:343-5.

[23] Tilak SP, Howard JM. Regeneration and Autotransplantation of Lymph Nodes. Ann Surg 1965;161:441-6.

[24] Shesol BF, Nakashima R, Alavi A, Hamilton RW. Successful Lymph Node Transplantation in Rats, with Restoration of Lymphatic Function. Plast Reconstruct Surg 1979;63:817-23.

[25] Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. The PRISMA Statement for Reporting Systematic Reviews and Meta-analyses of Studies that Evaluate Healthcare Interventions: Explanation and Elaboration. BMJ 2009;339:b2700.

[26] Frueh FS, Jelvani B, Scheuer C, Körbel C, Kim BS, Giovanoli P, et al. Short-term Molecular and Cellular Effects of Ischemia/Reperfusion on Vascularized Lymph Node Flaps in Rats. PLoS One 2020;15:e0239517.

[27] Tinhofer IE, Yang CY, Chen C, Cheng MH. Impacts of Arterial Ischemia or Venous Occlusion on Vascularized Groin Lymph Nodes in a Rat Model. J Surg Oncol 2020;121:153-62.

[28] Perrault DP, Lee GK, Bouz A, Sung C, Yu R, Pourmoussa AJ, et al. Ischemia and Reperfusion Injury in Superficial Inferior Epigastric Artery-based Vascularized Lymph Node Flaps. PLoS One 2020;15:e0227599.

[29] Yang CY, Ho OA, Cheng MH, Hsiao HY. Critical Ischemia Time, Perfusion, and Drainage Function of Vascularized Lymph Nodes. Plast Reconstruct Surg 2018;142:688-97.

[30] Kwiecien GJ, Gharb BB, Tadisina KK, Madajka M, Drazba J, Zins JE, et al. Quantity of Lymph Nodes in the Vascularized Lymph Node Transfer Influences Its Lymphaticovenous Drainage. J Reconstruct Microsurg 2018;34:41-6.

[31] Najjar M, Lopez MM Jr., Ballestin A, Munabi N, NaidesAI, Noland RD, et al. Reestablishment of Lymphatic Drainage after Vascularized Lymph Node Transfer in a Rat Model. Plast Reconstruct Surg 2018;142:503e-8.

[32] Aydogdu IO, Demir A, Keles MK, Yapici O, Yildizy L, Demirtas Y. Pedicled Vascularized Lymph Node Transfer Treats Lymphedema in Rat Hind Limb: A Simple Experimental Study Design. Lymphology 2017;50:27-35.

[33] Nguyen DH, Chou PY, Hsieh YH, Momeni A, Fang YH, Patel KM, et al. Quantity of Lymph Nodes Correlates with Improvement in Lymphatic Drainage in Treatment of Hind Limb Lymphedema with Lymph Node Flap Transfer in Rats. Microsurgery 2016;36:239-45.

[34] Ito R, Zelken J, Yang CY, Lin CY, Cheng MH. Proposed Pathway and Mechanism of Vascularized Lymph Node Flaps. Gynecol Oncol 2016;141:182-8.

[35] Visconti G, Brunelli C, Mulè A, Franceschini G, Chen HC, Masetti R, et al. Septum-based Cervical Lymph-node Free Flap in Rat: A New Model. J Surg Res 2016;201:1-12.

[36] Visconti G, Constantinescu T, Chen PY, Salgarello M, Franceschini G, Masetti R, et al. The Venous Lymph Node Flap: Concepts, Experimental Evidence, and Potential Clinical Implications. J Reconstruct Microsurg 2016;32:625-31.

[37] Kwiecien GJ, Uygur S, Korn J, Gharb BB, Madajka M, Djohan R, et al. Vascularized Axillary Lymph Node Transfer: A Novel Model in the Rat. Microsurgery 2015;35:662-7.

[38] Schindewolffs L, Breves G, Buettner M, Hadamitzky C, Pabst R. Vegf-c Improves Regeneration and Lymphatic Reconnection of Transplanted Autologous Lymph Node Fragments: An Animal Model for Secondary Lymphedema Treatment. Immunity Inflamm Dis 2014;2:152-61.

[39] Cheng MH, Huang JJ, Wu CW, Yang CY, Lin CY, Henry SL, et al. The Mechanism of Vascularized Lymph Node Transfer for Lymphedema: Natural Lymphaticovenous Drainage. Plast Reconstruct Surg 2014;133:192e-8.

[40] Uygur S, Ozturk C, Bozkurt M, Kwiecien G, Madajka M, Siemionow M. A New Vascularized Cervical Lymph Node Transplantation Model: An Anatomic Study in Rats. Ann Plast Surg 2013;71:671-4.

[41] Sommer T, Buettner M, Bruns F, Breves G, Hadamitzky C, Pabst R. Improved Regeneration of Autologous Transplanted Lymph Node Fragments by VEGF-C Treatment. Anat Rec (Hoboken) 2012;295:786-91.

[42] Hadamitzky C, Blum KS, Pabst R. Regeneration of Autotransplanted Avascular Lymph Nodes in the Rat is Improved by Platelet-rich Plasma. J Vasc Res 2009;46:389-96.

[43] Ishikawa K, Funayama E, Maeda T, Hayashi T, Murao N, Osawa M, et al. Changes in High Endothelial Venules in Lymph Nodes after Vascularized and Nonvascularized Lymph Node Transfer in a Murine Autograft Model. J Surg Oncol 2019;119:700-7.

[44] Ishikawa K, Maeda T, Funayama E, Hayashi T, Murao N, Osawa M, et al. Feasibility of Pedicled Vascularized Inguinal Lymph Node Transfer in a Mouse Model: A Preliminary Study. Microsurgery 2019;39:247-54.

[45] Maeda T, Yamamoto Y, Iwasaki D, Hayashi T, Funayama E, Oyama A, et al. Lymphatic Reconnection and Restoration of Lymphatic Flow by Nonvascularized Lymph Node Transplantation: Real-Time Fluorescence Imaging Using Indocyanine Green and Fluorescein Isothiocyanatedextran. Lymphatic Res Biol 2018;16:165-73.

[46] Hayashida K, Yoshida S, Yoshimoto H, Fujioka M, Saijo H, Migita K, et al. Adipose-derived Stem Cells and Vascularized Lymph Node Transfers Successfully Treat Mouse Hindlimb Secondary Lymphedema by Early Reconnection of the Lymphatic System and Lymphangiogenesis. Plast Reconstruct Surg 2017;139:639-51.

[47] Huang JJ, Gardenier JC, Hespe GE, Nores GD, Kataru RP, Ly CL, et al. Lymph Node Transplantation Decreases Swelling and Restores Immune Responses in a Transgenic Model of Lymphedema. PLoS One 2016;11:e0168259.

[48] Shioya R, Furukawa H, Murao N, Hayashi T, Oyama A, Funayama E, et al. Prevention of Lymphedematous Change in the Mouse Hindlimb by Nonvascularized Lymph Node Transplantation. Ann Plast Surg 2016;76:442-5.

[49] Tervala TV, Hartiala P, Tammela T, Visuri MT, YläHerttuala S, Alitalo K, et al. Growth Factor Therapy and Lymph Node Graft for Lymphedema. J Surg Res 2015;196:200-7.

[50] Tammela T, Saaristo A, Holopainen T, Lyytikkä J, Kotronen A, Pitkonen M, et al. Therapeutic Differentiation and Maturation of Lymphatic Vessels after Lymph Node Dissection and Transplantation. Nat Med 2007;13:1458-66.

[51] Suami H, Scaglioni MF, Dixon KA, Tailor RC. Interaction between Vascularized Lymph Node Transfer and Recipient Lymphatics after Lymph Node Dissection-a Pilot Study in a Canine Model. J Surg Res 2016;204:418-27.

[52] Chen HC, O’Brien BM, Rogers IW, Pribaz JJ, Eaton CJ. Lymph Node Transfer for the Treatment of Obstructive Lymphoedema in the Canine Model. Br J Plast Surg 1990;43:578-86.

[53] Hadamitzky C, Peric H, Theobald SJ, Gratz KF, Spohr H, Pabst R, et al. Effect of Cryopreservation on Lymph Node Fragment Regeneration after Autologous Transplantation in the Minipig Model. Innov Surg Sci 2018;3:139-46.

[54] Blum KS, Hadamitzky C, Gratz KF, Pabst R. Effects of Autotransplanted Lymph Node Fragments on the Lymphatic System in the Pig Model. Breast Cancer Res Treat 2010;120:59-66.

[55] Pabst R, Rothkötter HJ. Regeneration of Autotransplanted Lymph Node Fragments. Cell Tissue Res 1988;251:597-601.

[56] Lähteenvuo M, Honkonen K, Tervala T, Tammela T, Suominen E, Lähteenvuo J, et al. Growth Factor Therapy and Autologous Lymph Node Transfer in Lymphedema. Circulation 2011;123:613-20.

[57] Penuela RF, Arazo LC, Ayala JM. Outcomes in Vascularized Lymph Node Transplantation in Rabbits: A Reliable Model for Improving the Surgical Approach to Lymphedema. Lymphat Res Biol 2019;17:413-7.

[58] Tobbia D, Semple J, Baker A, Dumont D, Johnston M. Experimental Assessment of Autologous Lymph Node Transplantation as Treatment of Postsurgical Lymphedema. Plast Reconstruct Surg 2009;124:777-86.

[59] Frueh FS, Gousopoulos E, Rezaeian F, Menger MD, Lindenblatt N, Giovanoli P. Animal Models in Surgical Lymphedema Research--a Systematic Review. J Surg Res 2016;200:208-20.

[60] Homans J, Drinker CK, Field M. Elephantiasis and the Clinical Implications of its Experimental Reproduction in Animals. Ann Surg 1934;100:812-32.

[61] Hayes SC, Johansson K, Stout NL, Prosnitz R, Armer JM, Gabram S, et al. Upper-body Morbidity after Breast Cancer: Incidence and Evidence for Evaluation, Prevention, and Management within a Prospective Surveillance Model of Care. Cancer 2012;118:2237-49.

[62] McLaughlin SA, Wright MJ, Morris KT, Giron GL, Sampson MR, Brockway JP, et al. Prevalence of Lymphedema in Women with Breast Cancer 5 Years after Sentinel Lymph Node Biopsy or Axillary Dissection: Objective Measurements. J Clin Oncol 2008;26:5213-9.

[63] Jun H, Lee JY, Kim JH, Noh M, Kwon TW, Cho YP, et al. Modified Mouse Models of Chronic Secondary Lymphedema: Tail and Hind Limb Models. Ann Vasc Surg 2017;43:288-95.

[64] Tammela T, Alitalo K. Lymphangiogenesis: Molecular Mechanisms and Future Promise. Cell 2010;140:460-76.

[65] Ferrara N, Kerbel RS. Angiogenesis as a Therapeutic Target. Nature 2005;438:967-974.

[66] Stacker SA, Stenvers K, Caesar C, Vitali A, Domagala T, Nice E, et al. Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers. J Biol Chem 1999;274:32127-36.

[67] Joukov V, Sorsa T, Kumar V, Jeltsch M, ClaessonWelsh L, Cao Y, et al. Proteolytic Processing Regulates Receptor Specificity and Activity of VEGF-C. EMBO J 1997;16:3898-911.

[68] Scavelli C, Weber E, Aglianò M, Cirulli T, Nico B, VaccaA, et al. Lymphatics at the crossroads of angiogenesis and lymphangiogenesis. J Anat 2004;204:433-49.

[69] Mäkinen T, Jussila L, Veikkola T, Karpanen T, Kettunen MI, Pulkkanen KJ, et al. Inhibition of Lymphangiogenesis with Resulting Lymphedema in Transgenic Mice Expressing Soluble VEGF Receptor-3. Nat Med 2001;7:199-205.

[70] van den Dolder J, Mooren R, Vloon AP, Stoelinga PJ, Jansen JA. Platelet-rich Plasma: Quantification of Growth Factor Levels and the Effect on Growth and Differentiation of Rat Bone Marrow Cells. Tissue Eng 2006;12:3067-73.

[71] Stacker SA, Farnsworth RH, Karnezis T, Shayan R, Smith DP, Paavonen K, et al. Molecular Pathways for Lymphangiogenesis and their Role in Human Disease. Novartis Found Symp 2007;281:38-43.

[72] Gousopoulos E, Proulx ST, Bachmann SB, Scholl J, Dionyssiou D, Demiri E, et al. Regulatory T Cell Transfer Ameliorates Lymphedema and Promotes Lymphatic Vessel Function. JCI Insight 2016;1:e89081.

[73] Shimizu Y, Shibata R, Shintani S, Ishii M, Murohara T. Therapeutic Lymphangiogenesis with Implantation of Adipose-derived Regenerative Cells. J Am Heart Assoc 2012;1:e000877.

[74] Dai T, Jiang Z, Cui C, Sun Y, Lu B, Li H, et al. The Roles of Podoplanin-Positive/Podoplanin-Negative Cells from Adipose-Derived Stem Cells in Lymphatic Regeneration. Plastic Reconstruct Surg 2020;145:420-31.

[75] Kerrigan CL, Stotland MA. Ischemia Reperfusion Injury: A Review. Microsurgery 1993;14:165-75.

[76] Kerrigan CL, Daniel RK. Critical Ischemia Time and the Failing Skin Flap. Plastic Reconstruct Surg 1982;69:986-9.

[77] Siemionow M, Arslan E. Ischemia/Reperfusion Injury: A Review in Relation to Free Tissue Transfers. Microsurgery 2004;24:468-75.

[78] Suami H, Shin D, Chang DW. Mapping of Lymphosomes in the Canine Forelimb: Comparative Anatomy between Canines and Humans. Plastic Reconstruct Surg 2012;129:612-20.

[79] Tan JK, Watanabe T. Artificial Engineering of Secondary Lymphoid Organs. Adv Immunol 2010;105:131-57.

Share
Back to top
Journal of Clinical and Translational Research, Electronic ISSN: 2424-810X Print ISSN: 2382-6533, Published by AccScience Publishing